CompaniesByCap
SUPN
Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare

Supernus Pharmaceuticals Inc. Gross Margin 2010–2025

Current and historical gross margin for Supernus Pharmaceuticals Inc. (SUPN) over the last 10 years. The current gross profit margin for Supernus Pharmaceuticals Inc. as of December 31, 2025 is 89.63%.
From: 12/31/2010To: 12/31/2025
Revenue
Gross Profit
Gross Margin

Supernus Pharmaceuticals Inc. Gross Margin — FAQ

Supernus Pharmaceuticals Inc. (SUPN) gross margin over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

What is Supernus Pharmaceuticals Inc.'s gross margin?

Supernus Pharmaceuticals Inc. (SUPN) reported gross margin of 89.6% for fiscal 2025.

Where can I see SUPN's gross margin history?

The chart and table above show Supernus Pharmaceuticals Inc.'s gross margin by year and by quarter, including the growth rate.